VCAM1 and autoimmune polyendocrinopathy: Research findings indicate that aPL can trigger the activation of ECs in APS patients, resulting in an elevated release of TF, inflammatory factors, and adhesion molecules, for instance, ICAM-1, VCAM-1 and E-selectin.